ES2127919T3 - 4-amino-piridinas, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos. - Google Patents
4-amino-piridinas, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos.Info
- Publication number
- ES2127919T3 ES2127919T3 ES94909909T ES94909909T ES2127919T3 ES 2127919 T3 ES2127919 T3 ES 2127919T3 ES 94909909 T ES94909909 T ES 94909909T ES 94909909 T ES94909909 T ES 94909909T ES 2127919 T3 ES2127919 T3 ES 2127919T3
- Authority
- ES
- Spain
- Prior art keywords
- sup
- group
- atom
- compounds
- sub
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4306506A DE4306506A1 (de) | 1993-03-03 | 1993-03-03 | Neue 4-Alkylaminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| DE19934312966 DE4312966A1 (de) | 1993-04-21 | 1993-04-21 | Neue 4-Aminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2127919T3 true ES2127919T3 (es) | 1999-05-01 |
Family
ID=25923593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94909909T Expired - Lifetime ES2127919T3 (es) | 1993-03-03 | 1994-03-02 | 4-amino-piridinas, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0687253B1 (enExample) |
| JP (1) | JPH08507503A (enExample) |
| KR (1) | KR100252551B1 (enExample) |
| CN (1) | CN1046710C (enExample) |
| AT (1) | ATE174590T1 (enExample) |
| AU (1) | AU682026B2 (enExample) |
| CA (1) | CA2156729A1 (enExample) |
| CZ (1) | CZ225495A3 (enExample) |
| DE (1) | DE59407494D1 (enExample) |
| DK (1) | DK0687253T3 (enExample) |
| ES (1) | ES2127919T3 (enExample) |
| FI (1) | FI954105A0 (enExample) |
| GR (1) | GR3029691T3 (enExample) |
| HU (1) | HUT72898A (enExample) |
| IL (1) | IL108786A (enExample) |
| NO (1) | NO953447L (enExample) |
| NZ (1) | NZ262725A (enExample) |
| PL (1) | PL176455B1 (enExample) |
| RU (1) | RU2126388C1 (enExample) |
| SK (1) | SK108295A3 (enExample) |
| TW (1) | TW257757B (enExample) |
| WO (1) | WO1994020467A1 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4430755A1 (de) * | 1994-08-30 | 1996-03-07 | Boehringer Mannheim Gmbh | Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US5792769A (en) * | 1995-09-29 | 1998-08-11 | 3-Dimensional Pharmaceuticals, Inc. | Guanidino protease inhibitors |
| GB9525620D0 (en) * | 1995-12-15 | 1996-02-14 | Glaxo Group Ltd | Chemical compounds |
| CA2256309C (en) * | 1995-12-29 | 2006-08-15 | 3-Dimensional Pharmaceuticals, Inc. | Amidino protease inhibitors |
| US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
| GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
| SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
| WO1998006705A1 (en) * | 1996-08-14 | 1998-02-19 | Zeneca Limited | Substituted pyrimidine derivatives and their pharmaceutical use |
| AU725403B2 (en) * | 1996-09-13 | 2000-10-12 | Merck & Co., Inc. | Thrombin inhibitors |
| GB9821483D0 (en) | 1998-10-03 | 1998-11-25 | Glaxo Group Ltd | Chemical compounds |
| UA56197C2 (uk) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
| WO1998024760A1 (en) * | 1996-12-03 | 1998-06-11 | Graybill Todd L | Aminobenzenedicarboxylic acid-based combinatorial libraries |
| WO1998035956A1 (en) | 1997-02-13 | 1998-08-20 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| JP2001511799A (ja) | 1997-02-13 | 2001-08-14 | ゼネカ・リミテッド | オキシド−スクアレンシクラーゼ阻害剤として有用なヘテロ環式化合物 |
| GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| JP4327915B2 (ja) * | 1998-03-30 | 2009-09-09 | 株式会社デ・ウエスタン・セラピテクス研究所 | スルフォンアミド誘導体 |
| BR9914091A (pt) | 1998-10-06 | 2001-11-27 | Dainippon Pharmaceutical Co | Derivados de piridina 2,3-di-substituìda, processopara preparação dos mesmos, composições dedroga contendo os mesmos e intermediários paraa preparação |
| GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| JP2004505956A (ja) | 2000-08-04 | 2004-02-26 | ３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド | 環式オキシグアニジンプロテアーゼインヒビター |
| AU9233101A (en) * | 2000-10-04 | 2002-04-15 | Kissei Pharmaceutical | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| WO2002089740A2 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
| US6849635B2 (en) * | 2001-05-07 | 2005-02-01 | Smithkline Beecham Corporation | Sulfonamides |
| ATE402700T1 (de) | 2002-08-27 | 2008-08-15 | Merck Patent Gmbh | Glycinamid-derivate als raf-kinase-hemmer |
| MXPA05003054A (es) * | 2002-09-20 | 2005-05-27 | Pfizer Prod Inc | Ligandos de amida y sulfonamida para el receptor de estrogenos. |
| RU2374230C2 (ru) | 2003-11-05 | 2009-11-27 | Ф.Хоффманн-Ля Рош Аг | Фенильные производные в качестве ppar агонистов |
| WO2008104994A2 (en) * | 2007-02-28 | 2008-09-04 | Advinus Therapeutics Private Limited | 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| RU2353619C2 (ru) * | 2007-06-28 | 2009-04-27 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции |
| RU2354647C2 (ru) * | 2007-06-28 | 2009-05-10 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе |
| GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| US8265575B2 (en) * | 2009-06-16 | 2012-09-11 | Mediatek Inc. | Methods for handling a transmitting process and communication apparatuses utilizing the same |
| US8207639B2 (en) | 2009-10-23 | 2012-06-26 | Sunonwealth Electric Machine Industry Co., Ltd. | Motor and heating dissipating fan including motor having an annular balancing member |
| RU2685261C1 (ru) * | 2018-04-05 | 2019-04-17 | Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" | Вещество 4-амино-1-{ 2-[3-метил-5-(бензолсульфонилокси)фенокси] этил} -пиридиний хлорид, обладающее свойствами биологически активного агента, влияющими на естественно текущие процессы свертываемости крови млекопитающих, антикоагулянт на его основе и способ его получения путем химического синтеза |
| CN109172573B (zh) * | 2018-09-12 | 2021-01-26 | 黑龙江中桂制药有限公司 | 一种口服抗血栓药物及其用途 |
| CN110669337B (zh) * | 2019-07-08 | 2020-09-25 | 中国科学院长春应用化学研究所 | 一种芳香型二胺单体及其制备方法 |
| EP4716529A2 (en) * | 2023-05-23 | 2026-04-01 | Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center | Compounds that re-activate mutant p53 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1097620A1 (ru) * | 1983-02-16 | 1984-06-15 | Новокузнецкий научно-исследовательский химико-фармацевтический институт | Способ получени диэтил-N-(6-метилпиридил-2)-аминометиленмалоната |
| SU1318599A1 (ru) * | 1985-06-26 | 1987-06-23 | МГУ им.М.В.Ломоносова | Способ получени 1-алкил-2-хлор-2-алкоксиэтенилалкил(арил)хлорфосфинов |
| DE3529529A1 (de) * | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
| GB8819307D0 (en) * | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Antiarrhythmic agents |
| JPH0256465A (ja) * | 1988-08-22 | 1990-02-26 | Hamari Yakuhin Kogyo Kk | アセトアミド化合物 |
| US4885927A (en) * | 1988-09-12 | 1989-12-12 | General Motors Corporation | Method and apparatus for press forming intricate metallic shapes such as spool valve elements |
| EP0610432A1 (en) * | 1991-10-31 | 1994-08-17 | Smithkline Beecham Corporation | C8-cyclic peptidomimetics as fibrinogen antagonists |
| JPH07501063A (ja) * | 1991-11-14 | 1995-02-02 | グラクソ、グループ、リミテッド | フィブリノーゲン依存性血小板凝集阻害剤としてのピペリジン酢酸誘導体 |
| DE4212304A1 (de) * | 1992-04-13 | 1993-10-14 | Cassella Ag | Asparaginsäurederivate, ihre Herstellung und Verwendung |
-
1994
- 1994-02-22 TW TW083101504A patent/TW257757B/zh active
- 1994-02-28 IL IL10878694A patent/IL108786A/en not_active IP Right Cessation
- 1994-03-02 WO PCT/EP1994/000608 patent/WO1994020467A1/de not_active Ceased
- 1994-03-02 AU AU62574/94A patent/AU682026B2/en not_active Ceased
- 1994-03-02 EP EP94909909A patent/EP0687253B1/de not_active Expired - Lifetime
- 1994-03-02 DK DK94909909T patent/DK0687253T3/da active
- 1994-03-02 DE DE59407494T patent/DE59407494D1/de not_active Expired - Fee Related
- 1994-03-02 RU RU95122612A patent/RU2126388C1/ru active
- 1994-03-02 HU HU9502568A patent/HUT72898A/hu unknown
- 1994-03-02 SK SK1082-95A patent/SK108295A3/sk unknown
- 1994-03-02 PL PL94310520A patent/PL176455B1/pl unknown
- 1994-03-02 CN CN94191554A patent/CN1046710C/zh not_active Expired - Fee Related
- 1994-03-02 CZ CZ952254A patent/CZ225495A3/cs unknown
- 1994-03-02 FI FI954105A patent/FI954105A0/fi unknown
- 1994-03-02 ES ES94909909T patent/ES2127919T3/es not_active Expired - Lifetime
- 1994-03-02 NZ NZ262725A patent/NZ262725A/en unknown
- 1994-03-02 AT AT94909909T patent/ATE174590T1/de not_active IP Right Cessation
- 1994-03-02 KR KR1019950703694A patent/KR100252551B1/ko not_active Expired - Fee Related
- 1994-03-02 CA CA002156729A patent/CA2156729A1/en not_active Abandoned
- 1994-03-02 JP JP6519556A patent/JPH08507503A/ja active Pending
-
1995
- 1995-09-01 NO NO953447A patent/NO953447L/no unknown
-
1999
- 1999-03-16 GR GR990400775T patent/GR3029691T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9502568D0 (en) | 1995-11-28 |
| JPH08507503A (ja) | 1996-08-13 |
| IL108786A0 (en) | 1994-06-24 |
| EP0687253B1 (de) | 1998-12-16 |
| NO953447D0 (no) | 1995-09-01 |
| SK108295A3 (en) | 1996-06-05 |
| CN1046710C (zh) | 1999-11-24 |
| DE59407494D1 (de) | 1999-01-28 |
| RU2126388C1 (ru) | 1999-02-20 |
| EP0687253A1 (de) | 1995-12-20 |
| NO953447L (no) | 1995-09-01 |
| FI954105A7 (fi) | 1995-09-01 |
| CZ225495A3 (en) | 1996-01-17 |
| KR960701019A (ko) | 1996-02-24 |
| ATE174590T1 (de) | 1999-01-15 |
| IL108786A (en) | 1999-04-11 |
| FI954105A0 (fi) | 1995-09-01 |
| KR100252551B1 (ko) | 2000-05-01 |
| WO1994020467A1 (de) | 1994-09-15 |
| PL176455B1 (pl) | 1999-05-31 |
| AU6257494A (en) | 1994-09-26 |
| AU682026B2 (en) | 1997-09-18 |
| PL310520A1 (en) | 1995-12-27 |
| DK0687253T3 (da) | 1999-08-23 |
| CA2156729A1 (en) | 1994-09-15 |
| HUT72898A (en) | 1996-06-28 |
| CN1119858A (zh) | 1996-04-03 |
| TW257757B (enExample) | 1995-09-21 |
| GR3029691T3 (en) | 1999-06-30 |
| NZ262725A (en) | 1997-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| ES8400444A1 (es) | Procedimiento para la preparacion de nuevos derivados de carbapenem. | |
| ES8304147A1 (es) | Procedimiento para la preparacion de mono-esteres amonio-al-cohilicos de acidos alcanol-fosforicos | |
| ES8604226A1 (es) | Procedimiento para preparar (2-oxo-1, 2, 3, 5-tetrahidroimidazo (2, 1-b) quinazolinil) oxialquilamidas | |
| ES2111169T3 (es) | Dicetopiperazinas farmaceuticamente activas. | |
| CO4970728A1 (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados | |
| ES2011210T3 (es) | Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2090855T3 (es) | Derivados de naftaleno, procedimientos para su preparacion y productos intermediarios apropiados. | |
| ES2026669T3 (es) | Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos. | |
| AR010129A1 (es) | Compuestos aminicos sustituidos, procedimiento de preparacion y su aplicacion como analgesico | |
| ES2029879T3 (es) | Procedimiento para producir derivados de aminas sustituidas. | |
| ES2111930T3 (es) | Antagonistas del acido amp y procedimientos de tratamiento con la ayuda de estos. | |
| ES8705453A1 (es) | Un procedimiento para la preparacion de derivados de cefalosporina. | |
| ES2140181T3 (es) | Androstenonas. | |
| ES8307824A1 (es) | Un procedimiento para preparar nuevos compuestos de cefem. | |
| ES2038766T3 (es) | 4-aril-5-carbamoil-1,4-dihidropiridinas. | |
| ES2153019T3 (es) | Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2095848T3 (es) | Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos. | |
| ES2056073T3 (es) | Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende. | |
| ES8301883A1 (es) | Procedimiento para la preparacion de derivados de ciclohexe-no | |
| ES2070002T3 (es) | Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona. | |
| ES2183492T3 (es) | Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES470296A1 (es) | Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos | |
| CO4410339A1 (es) | Derivados de arilalquilamino, proceso para su preparacion y composiciones farmaceuticas que comprenden estos compuestos | |
| ES2153457T3 (es) | Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 687253 Country of ref document: ES |